The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...
A single hepatitis B injection set off a lasting immune response, and two patients reached a functional cure that held for ...
A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...
The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
8d
How a new drug shows promise as a 'functional cure' for Long Island's chronic hepatitis B patients
In about 20% of the drug's recipients, the virus remained undetectable for at least six months after all treatments were ...
The U.S. Food and Drug Administration has approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta ...
Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...
The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
Hepatitis B is a serious liver disease caused by the hepatitis B virus (HBV), which is a small DNA virus from the Hepadnaviridae family. If someone has this infection for a long time, it can lead to ...
This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the third installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...
Viral hepatitis is an infection of the liver with one of five strains of the hepatitis virus (A, B, C, D, or E), resulting in liver inflammation and damage. Hepatitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results